Response to "knowledge mapping of immunotherapy for breast cancer: A bibliometric analysis from 2013 to 2022: A correspondence"
- PMID: 38860970
- PMCID: PMC11178328
- DOI: 10.1080/21645515.2024.2360826
Response to "knowledge mapping of immunotherapy for breast cancer: A bibliometric analysis from 2013 to 2022: A correspondence"
Conflict of interest statement
No potential conflict of interest was reported by the author(s).
Comment on
-
Knowledge mapping of immunotherapy for breast cancer: A bibliometric analysis from 2013 to 2022.Hum Vaccin Immunother. 2024 Dec 31;20(1):2335728. doi: 10.1080/21645515.2024.2335728. Epub 2024 Apr 2. Hum Vaccin Immunother. 2024. PMID: 38563136 Free PMC article. Review.
References
-
- Qu F, Wang G, Wen P, Liu X, Zeng X.. Knowledge mapping of immunotherapy for breast cancer: A bibliometric analysis from 2013 to 2022. Hum Vaccin Immunother. 2024;20(1):2335728. Epub 2024/04/02. doi: 10.1080/21645515.2024.2335728. PubMed PMID: 38563136; PubMed Central PMCID: PMCPMC10989689. - DOI - PMC - PubMed
-
- Jiang S, Liu Y, Zheng H, Zhang L, Zhao H, Sang X, Xu Y, Lu X. Evolutionary patterns and research frontiers in neoadjuvant immunotherapy: a bibliometric analysis. Int J Surg. 2023;109(9):2774–2. Epub 2023/05/22. doi: 10.1097/JS9.0000000000000492. PubMed PMID: 37216225; PubMed Central PMCID: PMCPMC10498839. - DOI - PMC - PubMed
-
- Zhang L, Zheng H, Jiang ST, Liu YG, Zhang T, Zhang JW, Lu X, Zhao H-T, Sang X-T, Xu Y-Y. Worldwide research trends on tumor burden and immunotherapy: a bibliometric analysis. Int J Surg. 2024;110(3):1699–710. Epub 2024/01/05. doi: 10.1097/JS9.0000000000001022. PubMed PMID: 38181123; PubMed Central PMCID: PMCPMC10942200. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical